Chad vs Mus: The number of people with susceptibility test result for rifampicin
Chad
100
in 2021
Mus
100
in 2021
Chad rank
2nd
Mus rank
1st
The number of people with susceptibility test result for rifampicin over time
- Chad
- Mus
How they compare
Chad currently reports 100 against 100 in Mus, a difference of 0.
Across all 5 years both countries report, Mus has been ahead every year.
Chad ranks 2nd and Mus ranks 1st of 146 countries.
Mus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.46 | 100 | 87.54 | Mus |
| 2020s | 69.28 | 100 | 30.72 | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chad or Mus?
- Chad, at 100 against 100 in Mus as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chad and Mus?
- 0, with Chad ahead.
- How many years of comparable data are there for Chad and Mus?
- 5 years are reported by both, from 2017 to 2021.
- How do Chad and Mus rank globally for the number of people with susceptibility test result for rifampicin?
- Chad ranks 2nd and Mus ranks 1st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.